Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Open Access
- 7 May 2024
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 34, 100759
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 DiabetesJACC, 2020
- The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDEuropean Heart Journal, 2019
- Projecting ESRD Incidence and Prevalence in the United States through 2030Journal of the American Society of Nephrology, 2018
- Identifying diabetes cases from administrative data: a population-based validation studyBMC Health Services Research, 2018
- Effect of Out‐of‐Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE)Health Services Research, 2017
- Structural racism and health inequities in the USA: evidence and interventionsThe Lancet, 2017
- Physicians and Implicit Bias: How Doctors May Unwittingly Perpetuate Health Care DisparitiesJournal of General Internal Medicine, 2013
- Automated Detection and Classification of Type 1 Versus Type 2 Diabetes Using Electronic Health Record DataDiabetes Care, 2013
- Association of socio-economic status with diabetes prevalence and utilization of diabetes care servicesBMC Health Services Research, 2006
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004